Christopher M. Cronin

Host Hotels & Resorts, Inc. (NASDAQ: HST) (the Company), the nation’s largest lodging real estate investment trust, has announced that Host Hotels & Resorts, L.P. (Host L.P.), for whom the Company acts as sole general partner, has priced its offering (the Offering) of US$600 million aggregate principal amount of 5.700% Senior Notes due 2034 (the Notes). The Offering closed on May 10, 2024. Host L.P. intends to allocate an amount equal to the net proceeds from the sale of the Notes to finance and/or refinance one or more eligible green projects. Latham & Watkins LLP represented Host Hotels & Resorts in the offering with a capital markets team led by New York/Washington, D.C. partner Jason Licht and Washington, D.C. counsels Christopher Cronin and Jess Lennon, with associates Gabrielle Blum and Claudia Dubay. Advice was also provided on sustainability finance matters by Riyadh partner Edward Kempson, with associate Peter Neuböck, and on public company matters by Washington, D.C. partners Joel Trotter and Julia Thompson.~~

May 10

1 min

Latham & Watkins represented Arrow Electronics, Inc., a technology solutions company, in a public offering of US$500 million of 5.875% notes due 2034. Arrow used the proceeds from the offering to redeem all of Arrow's 6.125% notes due 2026. The notes were rated Baa3 by Moody’s, BBB- by S&P Global, and BBB- by Fitch. Latham corporate partners Roderick Branch and Michael Treska led the Latham team, with counsel Christopher Cronin and associates Andrew Rutsky, Joann Murphy, Ryan Hudson, and Cyerra McGowan. Advice was also provided on tax matters by partners Joseph Kronsnoble and Rene de Vera, with associate Valerie Silva Parra.~~

Apr 30

1 min

On May 9, 2023, Corning Incorporated, one of the world’s leading innovators in materials science, priced €300,000,000 principal amount of 3.875% notes due 2026 and €550,000,000 principal amount of 4.125% notes due 2031. Latham & Watkins LLP represented Corning Incorporated in the offerings with a Washington, D.C.-based capital markets team led by partners Julia Thompson and Jason Licht and counsel Christopher Cronin, with associate Kaan Ulgen. Advice was also provided on tax matters by Century City partners Pardis Zomorodi and Ana O’Brien, with associate Kathryn Harrington.~~

May 15

1 min

Quidel Corporation (NASDAQ: QDEL) (Quidel) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (Ortho) have announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies, for US$24.68 per share of common stock using a combination of cash and newly issued shares in the combined company, representing a 25% premium over Ortho’s closing price on December 22, 2021 and an equity value of approximately US$6.0 billion. The transaction is expected to close during the first half of fiscal year 2022, subject to customary closing conditions. Latham & Watkins LLP represents Ortho in the transaction with a corporate deal team led by Washington, D.C. partner David Brown and associate Mariclaire Petty, together with Chicago partner Bradley Faris and London partner Richard Butterwick, with Washington, D.C. associates Jill Rubinger and Madeline Merkle, Chicago associate Michael Magstadt, and London associate Harry Redford. Advice was also provided on tax matters by New York partner David Raab, London partner Sean Finn, and New York partner Matthew Dewitz, with associate Shruti Hazra; on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum, with associate Kirk Porter; on antitrust and foreign direct investment (FDI) matters by Washington, D.C. partner Jason Cruise, Brussels partner Luca Crocco, and Hamburg counsel Jana de Chapto Dammann, with associates Alexandra Clark and Nicolas Jung; on capital markets matters by Washington, D.C. partners Patrick Shannon and Jason Licht and Washington, D.C. counsel Christopher Cronin; on finance matters by Washington, D.C. partners Jeffrey Chenard, Scott Forchheimer, and Benjamin Berman; on environmental matters by Washington, D.C. partner James Barrett, with associate Phil Sandick; on real estate matters by New York partner Dara Denberg and New York counsel Shira Bressler, with associate Thomas Ficchi; on healthcare regulatory matters by Washington, D.C. partners Elizabeth Richards and Eric Greig and Bay Area counsel Betty Pang, with associates Nathan Beaton, Brian Goodell, Lee Staley, and Leia Gu; on anti-corruption matters by Washington, D.C. partner Brian Kowalski, with associate Faiza Hasan; on CFIUS and export controls and sanctions matters by Washington, D.C. partner Les Carnegie, with associate Julie Choi Shin; and on data privacy matters by London partner Gail Crawford and Bay Area counsel Heather Deixler, with associates Jane Bentham and Kate Burrell.~~

Dec 23

2 min

Latham & Watkins LLP advised Carlyle on a US$1.01 billion high yield bond offering that was recognized as High Yield Bond of the Year at IFR Asia’s 2021 Awards. The bond, which was sold as part of a bridge-to-bond transaction unique to the region, helped to fund Carlyle’s acquisition of Mumbai, India-based Hexaware Technologies, a leading global IT consulting and digital solutions provider. The Latham capital markets team that advised Carlyle on the offering was led by Washington, D.C. partner Jason Licht and Washington, D.C. counsel Christopher Cronin, with associates John Fluharty and Gary DePalo, along with a finance team led by Washington, D.C. partner Jeffrey Chenard, with associates Marie Greenman and James Kachadoorian, and with assistance from Hong Kong partner Andrew Bishop and Hong Kong counsel Lynsey Edgar.~~

Apr 15

1 min